Narrow Band Imaging Versus White Light for the Detection and Miss of Sessile Serrated Lesion
1 other identifier
interventional
840
1 country
1
Brief Summary
Narrow band imaging(NBI) could improve the detection of colorectal lesions, previous investigations demonstrated its potential in detecting not only colorectal adenoma but non-adenomatous polyps, including sessile serrated lesions. But no randomized controlled trials with NBI versus white light imaging(WLI) have been conducted to give a definitive conclusion with statistically significant differences. Therefore, we performed a multicenter, prospective, back to back, randomized controlled trial to compare sessile serrated lesions detection and miss rate of withdraw by NBI and WLI in colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2023
CompletedFirst Posted
Study publicly available on registry
January 13, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2024
CompletedMarch 15, 2024
March 1, 2024
1.2 years
January 5, 2023
March 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
sessile serrated lesions miss rate(SSLMR)
Sessile serrated lesions(SSLs) detected in the second-pass examination were defined as missed SSLs; the sessile serrated lesions miss rate(SSLMR) was defined as follows: number of SSLs detected in the second-pass examination/total number of SSLs detected in both two pass.
60 minutes
Secondary Outcomes (3)
sessile serrated lesions detection rate(SSLDR)
60 minutes
adenoma miss rate(AMR)
60 minutes
adenoma detection rate(ADR)
60 minutes
Study Arms (2)
WLI Then NBI Withdrawal Group
EXPERIMENTALAfter successful intubation of the cecum, carefully inspect the whole colorectal mucosa by white light imaging(WLI) during the first colonoscopy withdraw. Then reinsert to the cecum and withdraw with narrow band imaging(NBI). Stop watch will be utilized to remind endoscopists.
NBI Then WLI Withdrawal Group
ACTIVE COMPARATORAfter successful intubation of the cecum, carefully inspect the whole colorectal mucosa by narrow band imaging(NBI) during the first colonoscopy withdraw. Then reinsert to the cecum and withdraw with white light imaging(WLI). Stop watch will be utilized to remind endoscopists.
Interventions
Patients in WLI then NBI withdrawal group will first be carefully inspected by white light imaging(WLI), each polyp found should be removed. According to the ESGE guideline of colorectal polypectomy, the lesions which size between 4-9mm should by removed by cold snare. Cold biopsy forceps could be utilized considering the difficulty in resection of flat and diminutive polyps(size ≤ 3mm). Then change to narrow band imaging(NBI) for the second withdraw to detect the lesions which found in second time but not the first.
Patients in NBI then WLI withdrawal group will first be carefully inspected by narrow band imaging(NBI), each polyp found should be removed. According to the ESGE guideline of colorectal polypectomy, the lesions which size between 4-9mm should by removed by cold snare. Cold biopsy forceps could be utilized considering the difficulty in resection of flat and diminutive polyps(size ≤ 3mm). Then change to white light imaging(WLI) for the second withdraw to detect the lesions which found in second time but not the first.
Eligibility Criteria
You may qualify if:
- Patients whose age are between 45-85
- Patients who have indications for screening
- Patients who have signed inform consent form.
You may not qualify if:
- Patients who have undergone colonic resection
- Patients with alarming signs and symptoms of colorectal cancer: hematochezia, melena, anemia, weight loss, abdominal mass, positive digital rectal examination
- Patients with highly suspected or confirmed colorectal cancers by radiographic and laboratory tests
- Patients with abnormal blood coagulation or taking antiplatelets or anticoagulants within 7 days before colonoscopy
- Patients with inflammatory bowel diseases
- Patients with hereditary colorectal cancer syndrome (including familial adenomatous polyposis).
- Patients with pregnancy, severe chronic cardiopulmonary and renal disease.
- Patients with therapeutic colonoscopy for existing lesions
- Patients with failed cecal intubation
- Patients with poor bowel preparation quality that necessitated a second bowel preparation
- Patients refusing to participate or to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Changhai Hospitallead
- The First Affiliated Hospital of Dalian Medical Universitycollaborator
- The Second Hospital of Hebei Medical Universitycollaborator
- Yantaishan Hospitalcollaborator
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicinecollaborator
- 900 Hospital of Joint Logistics Support Force of PLAcollaborator
- Heilongjiang provincial hospitalcollaborator
- Ankang Central Hospitalcollaborator
- Nongken Jiansanjiang People Hospital of Heilongjiang Provincecollaborator
- Huadong Hospitalcollaborator
- The Second Affiliated Hospital of Baotou Medical Collegecollaborator
- Qilu Hospital of Shandong Universitycollaborator
- Shandong First Medical Universitycollaborator
- Air Force Military Medical University, Chinacollaborator
- Tengzhou Central People's Hospitalcollaborator
- Chongqing General Hospitalcollaborator
- Haikou People's Hospitalcollaborator
Study Sites (1)
Changhai Hospital, Second Military Medical University
Shanghai, Shanghai Municipality, 200433, China
Related Publications (4)
Zhao S, Song Y, Wang S, Wang R, Feng Z, Gong A, Yang X, Pan P, Yao D, Zhang J, Zhu Y, Li T, Bi J, Ren X, Tang X, Li Q, Yu D, Zheng J, Song B, Wang P, Chen W, Shang G, Xu Y, Xu P, Lai Y, Xu H, Yang X, Sheng J, Tao Y, Li X, Zhu Y, Zhang X, Shen H, Ma Y, Wang F, Wu L, Wang X, Li Z, Bai Y. Reduced Adenoma Miss Rate With 9-Minute vs 6-Minute Withdrawal Times for Screening Colonoscopy: A Multicenter Randomized Tandem Trial. Am J Gastroenterol. 2023 May 1;118(5):802-811. doi: 10.14309/ajg.0000000000002055. Epub 2022 Oct 11.
PMID: 36219172BACKGROUNDLi J, Zhang D, Wei Y, Chen K, Wu R, Peng K, Hou X, Li L, Huang C, Wang Y, Xun L, Xu H, Wang J, Chen Z, Shen M, Liu F. Colorectal Sessile Serrated Lesion Detection Using Linked Color Imaging: A Multicenter, Parallel Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2023 Feb;21(2):328-336.e2. doi: 10.1016/j.cgh.2022.03.033. Epub 2022 Apr 4.
PMID: 35390509BACKGROUNDRex DK, Clodfelter R, Rahmani F, Fatima H, James-Stevenson TN, Tang JC, Kim HN, McHenry L, Kahi CJ, Rogers NA, Helper DJ, Sagi SV, Kessler WR, Wo JM, Fischer M, Kwo PY. Narrow-band imaging versus white light for the detection of proximal colon serrated lesions: a randomized, controlled trial. Gastrointest Endosc. 2016 Jan;83(1):166-71. doi: 10.1016/j.gie.2015.03.1915. Epub 2015 May 5.
PMID: 25952085BACKGROUNDWei J, Zhang S, Fang Q, Sui X, Tang X, Shi L, Zhao Y, Hu H, Huang Z, Huang X, Zhang H, Wang S, Li X, Wang C, Guo Y, Xu B, Wu W, Su Y, Chen L, Wei R, Li P, Shi L, Tang B, Qiao X, Xu M, Zhang J, Ji R, Ji D, Gong A, Li B, Ren J, Jiang Z, Xu H, Li M, Wang W, Yu J, Feng Z, Zhang J, Yao D, Li Z, Zhao S, Bai Y. Impact of Narrow-Band Imaging on Sessile Serrated Lesion Miss Rate: A Multicenter Randomized Tandem Colonoscopy Trial. Clin Gastroenterol Hepatol. 2026 Feb 2:S1542-3565(26)00055-8. doi: 10.1016/j.cgh.2026.01.027. Online ahead of print.
PMID: 41638419DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Zhaoshen Li, MD
Changhai Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD,Director, Head of Department of Gastroenterology and Digestive Endoscopy Center, Principal Investigator
Study Record Dates
First Submitted
January 5, 2023
First Posted
January 13, 2023
Study Start
February 1, 2023
Primary Completion
March 28, 2024
Study Completion
May 28, 2024
Last Updated
March 15, 2024
Record last verified: 2024-03